Synapse - Ethan Barnett

Results (31)

Evaluation of preanalytic variables in liquid biopsy tests for prostate cancer: Specimen acquisition and patient context factors that impact results

Meeting Abstract

Tsui, D.; Barnett, E. S.; Bramlet, K.; Schonhoft, J.; Rizzi, R.; Scher, H. I.
Clinical Cancer Research (2020)

Fulltext@MSK | Save

Platinum-based chemotherapy in metastatic prostate cancer with DNA repair gene alterations

Journal Article

Mota, J. M.; Barnett, E.; Nauseef, J. T.; Nguyen, B.; Stopsack, K. H.; Wibmer, A.; Flynn, J. R.; Heller, G.; Danila, D. C.; Rathkopf, D.; more...
JCO Precision Oncology (2020)

Fulltext@MSK | Save

Clinical utility of the nuclear-localized AR-V7 biomarker in circulating tumor cells in improving physician treatment choice in castration-resistant prostate cancer

Journal Article

Graf, R. P.; Hullings, M.; Barnett, E. S.; Carbone, E.; Dittamore, R.; Scher, H. I.
European Urology (2020)

Fulltext@MSK | Save

Toward standardization of preanalytical procedures for cell-free DNA profiling

Editorial

Tsui, D. W. Y.; Barnett, E.; Scher, H. I.
Clinical Chemistry (2020)

Fulltext@MSK | Save

CTC versus biopsy tissue sequencing: A concordance analysis of genomic copy number profile from mCRPC patients (pts)

Meeting Abstract

Scher, H. I.; Lee, J.; Dago, A. E.; Barnett, E.; Sutton, R.; Carbone, E.; Schreiber, N. A.; Hullings, M.; Ebrahim, N.; Landers, M. A.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Examination of the additive value of CTC biomarkers of heterogeneity (Het) and chromosomal instability to nuclear-localized (nl) AR-V7+CTCs in prediction of poor outcomes to androgen receptor signaling inhibitor (ARSi) in metastatic castration resistant prostate cancer (mCRPC)

Meeting Abstract

Scher, H. I.; Schonhoft, J.; Graf, R. P.; Jendrisak, A.; Barnett, E.; Jayaram, A.; Winquist, E.; Landers, M.; Wang, Y.; Allan, A. L.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Platinum-based chemotherapy in metastatic prostate cancer with alterations in DNA damage repair genes

Meeting Abstract

Mota, J. M.; Barnett, E.; Nauseef, J.; Stopsack, K. H.; Wibmer, A. G.; Danila, D. C.; Rathkopf, D. E.; Slovin, S. F.; Kantoff, P. W.; Scher, H. I.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Morphology-predicted, large-scale transition (LST) number in circulating tumor cells (CTC) as a biomarker of chromosomal instability (CIN) to assess early resistance to standard of care (SOC) drugs in mCRPC

Meeting Abstract

Scher, H. I.; Schonhoft, J.; Hullings, M.; Carbone, E.; Barnett, E.; Sutton, R.; Jendrisak, A.; Landers, M. A.; Wang, Y.; Dittamore, R.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Characterization of SLFN11 protein expression in circulating tumor cells (CTCs) of patients with metastatic castration resistant prostate cancer (mCRPC) prior to platinum based chemotherapy